Duopharma net profit rises 15% in 1Q


Duopharma Biotech group managing director Leonard Ariff Abdul Shatar

KUALA LUMPUR: Duopharma Biotech Bhd’s net profit rose 15.2% to RM20.29mil in the first quarter ended March 31 against RM17.61mil a year ago on higher sales.

The pharmaceutical group saw its revenue rise 11.7% to RM185.94mil from RM166.45mil a year prior. Its earnings per share for the quarter stood at 2.19 sen, compared with 1.90 sen last year.

Get 20% OFF The Star Digital Access

Monthly Plan

RM 13.90/month

RM 11.12/month

Billed as RM 11.12 for the 1st month, RM 13.90 thereafter.

Best Value

Annual Plan

RM 12.33/month

RM 9.87/month

Billed as RM 118.40 for the 1st year, RM 148 thereafter.

Follow us on our official WhatsApp channel for breaking news alerts and key updates!

Next In Business News

Suzhou builds photonics powerhouse
Building momentum selectively
Zero tolerance for corruption
Lotte Chemical Titan sale sparks hope but challenges remain
MY Value Up must measure up
A new reality for crypto
Ekovest’s rights issue tests investors’ faith
Mr. Robot comes to town
Big Tech’s debt drives credit risk
An appetite for fresh snacks

Others Also Read